Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP19A1 | P11511 | 1/20 | 0.54 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.48 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.48 |
| ▸ | TSHR | P16473 | 4/20 | 0.47 |
| ▸ | LMNA | P02545 | 2/20 | 0.46 |
| ▸ | MEN1 | O00255 | 3/20 | 0.45 |
| ▸ | HTT | P42858 | 3/20 | 0.45 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.45 |
| ▸ | VCAM1 | P19320 | 1/20 | 0.45 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.43 |
| ▸ | TTR | P02766 | 2/20 | 0.43 |
| ▸ | POLB | P06746 | 1/20 | 0.42 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.42 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.42 |
| ▸ | MAPT | P10636 | 1/20 | 0.42 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.42 |
| ▸ | HPGD | P15428 | 1/20 | 0.42 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.42 |
| ▸ | ALOX12 | P18054 | 1/20 | 0.42 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL561018 | 0.95 | CYP19A1 (0.48) | CYP19A1SMN1; SMN2CYP3A4TSHRLMNA | |
| SCHEMBL18407603 | 0.87 | TSHR (0.56) | CYP19A1SMN1; SMN2CYP3A4TSHRLMNA | |
| SCHEMBL11025268 | 0.87 | ACHE (0.54) | CYP19A1SMN1; SMN2TSHRLMNAMEN1 | |
| SCHEMBL30319435 | 0.87 | TSHR (0.56) | CYP19A1SMN1; SMN2CYP3A4TSHRLMNA | |
| SCHEMBL31347504 | 0.87 | ACHE (0.54) | CYP19A1SMN1; SMN2TSHRLMNAMEN1 | |
| SCHEMBL3912806 | 0.86 | ALDH1A1 (0.46) | CYP19A1SMN1; SMN2CYP3A4TSHRLMNA | |
| SCHEMBL10155626 | 0.86 | TSHR (0.63) | CYP19A1SMN1; SMN2TSHRLMNAMEN1 | |
| SCHEMBL31434425 | 0.86 | ACP1 (0.44) | CYP19A1SMN1; SMN2CYP3A4TSHRLMNA | |
| SCHEMBL1099111 | 0.86 | CYP4F2 (0.42) | CYP19A1SMN1; SMN2CYP3A4TSHRLMNA | |
| SCHEMBL922768 | 0.86 | NPC1 (0.47) | CYP19A1SMN1; SMN2CYP3A4TSHRLMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 248 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-118563576-B | Preparation method of antioxidant SBS modified asphalt waterproof coiled material | 北新防水(安徽)有限公司 | 2024-11-01 | — | — | CN | claimed |
| CN-118563576-A | Preparation method of antioxidant SBS modified asphalt waterproof coiled material | 北新防水(安徽)有限公司 | 2024-08-30 | — | — | CN | claimed |
| CN-116555080-A | Preparation method of hybrid ester compound containing oxazole ring | 上海交通大学医学院附属仁济医院 | 2023-08-08 | — | — | CN | claimed |
| CN-114988775-B | Self-repairing high-performance concrete | 浙江方远新材料股份有限公司 | 2023-07-14 | — | — | CN | claimed |
| CN-114605769-B | Polyamide color master batch colored by high-content carbon black for spinning and preparation method thereof | 广东九彩新材料有限公司 | 2023-01-17 | — | — | CN | claimed |
| CN-114988775-A | Self-repairing high-performance concrete | 浙江方远新材料股份有限公司 | 2022-09-02 | — | — | CN | claimed |
| CN-111138107-B | Microorganism immobilization method for self-repairing of concrete cracks | 浙江海洋大学 | 2021-11-23 | — | — | CN | claimed |
| CN-111393300-A | Novel method for synthesizing 3, 5-dinitrobenzyl chloride | 南京工业大学 | 2020-07-10 | — | — | CN | claimed |
| CN-111138107-A | Microorganism immobilization method for self-repairing of concrete cracks | 浙江海洋大学 | 2020-05-12 | — | — | CN | claimed |
| EP-0546390-A1 | Device for creatinine determination | Bayer Corporation (US) | 1993-06-16 | — | — | EP | claimed |
| EP-4707274-A1 | SP3-ANALOGUES OF AXITINIB AND MEDICAL USES THEREOF | Universidad Autónoma de Madrid (ES) | 2026-03-11 | — | — | EP | disclosed |
| CN-120775654-A | Bright laundry detergent without fluorescent whitening agent | 深圳市海量实业有限公司 | 2025-10-14 | — | — | CN | disclosed |
| CN-119972172-A | Heterogeneous organic polymer catalyst, preparation method thereof and method for synthesizing aldehyde or lactone compound | 武汉光化学技术研究院 | 2025-05-13 | — | — | CN | disclosed |
| CN-115490705-B | N-macrocyclic amide compound, preparation method thereof and application thereof as medicine | 成都凡诺西生物医药科技有限公司 | 2025-04-01 | — | — | CN | disclosed |
| US-20240425518-A1 | N-MACROCYCLIC AMIDE COMPOUNDS, PREPARATION METHODS THEREOF AND APPLICATIONS THEREOF AS MEDICAMENTS | CHENGDU FANXI BIOPHARMA CO., LTD. (CN) | 2024-12-26 | — | — | US | disclosed |
| US-4558117-A | Organic solvent-soluble photosensitive polyimide resin | UBE INDUSTRIES, LTD. (JP) | 1985-12-10 | — | — | US | disclosed |
| EP-0004447-B1 | PREPARATION OF TRIFLUOROMETHYLPHENOLS AND NOVEL TRIFLUOROMETHYLPHENYL BENZYL ETHER INTERMEDIATES | ELI LILLY AND COMPANY (US) | 1981-12-02 | — | — | EP | disclosed |
| US-4232032-A | GROWTH PROMOTERS | IMPERIAL CHEMICAL INDUSTRIES LIMITED (GB) | 1980-11-04 | — | — | US | disclosed |
| EP-0004447-A2 | Preparation of trifluoromethylphenols and novel trifluoromethylphenyl benzyl ether intermediates | ELI LILLY AND COMPANY (US) | 1979-10-03 | — | — | EP | disclosed |
| US-4168388-A | Trifluoromethylphenyl benzyl ethers | ELI LILLY AND COMPANY (US) | 1979-09-18 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240425518-A1 | N-MACROCYCLIC AMIDE COMPOUNDS, PREPARATION METHODS THEREOF AND APPLICATIONS THEREOF AS MEDICAMENTS | ZYX, MLX, LPXN | CYP19A1 321/4885SMN1; SMN2 3397/4885CYP3A4 252/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.